Director Global Evidence Generation Rare Disease

Director Global Evidence Generation Rare Disease 

Global Medical Affairs 

Global Rare Disease 

Novo Nordisk 

Are you motivated to shape how evidence is generated, integrated and translated into impact for people living with rare diseases? Do you combine strategic evidence leadership with the drive to turn scientific strategy into high-quality execution, launch readiness and stakeholder value? 

This senior role in Global Medical Affairs Rare Disease will set the direction for evidence generation across the Rare Disease portfolio while staying close to delivery. You will ensure evidence strategies are robust, actionable, and aligned with business priorities — translating plans into impactful studies, scientific communication, and practical insights that support decision-making. 

Your new role 

As Global Evidence Generation Director, you will lead and drive the global evidence generation strategy for Rare Disease in close partnership with therapy area medical teams, regions, key affiliates, clinical development, market access, commercial, safety, regulatory and external scientific stakeholders.  

You will be accountable for translating medical and business priorities into an integrated evidence generation approach that supports clinical practice change, scientific communication, and stakeholder engagement. The role requires strategic judgement, strong cross-functional leadership, and the ability to ensure that evidence activities are prioritised, compliant, scientifically robust and aligned with the Rare Disease ambition. 

Your key responsibilities will include: 

• Shape and lead the integrated evidence strategy across the Rare Disease portfolio and brands, ensuring evidence plans are aligned with therapy area strategies and business priorities. 

• Drive design and execution of priority real world evidence (RWE) and Investigator Sponsored Study (ISS) activities, providing expert input on study concepts, coordinating delivery across teams and markets, and ensuring evidence generation supports launch and lifecycle goals. 

• Lead and coordinate the evidence team, including Evidence Generation Associate Directors and Project Managers, ensuring clear priorities, strong execution, progress tracking and delivery against timelines, budgets and impact. 

• Translate evidence into impact, working with Publications, Scientific Communication and cross-functional teams to ensure study outputs are communicated effectively and embedded into key scientific dialogue deliverables. 

• Build evidence generation capability, acting as a subject matter expert and mentor for the evidence team and wider Medical Affairs organisation. 

• Partner across the enterprise, building strong collaboration with Medical Affairs, Commercial, Market Access, R&D, affiliates, RWE/Data Science experts and external stakeholders to address portfolio evidence needs. 

• Contribute to Medical Affairs functional leadership team, helping set direction, prioritise resources, develop talent and strengthen a state-of-the-art Medical Affairs organisation focused on advancing patient care. 

Your new department  

You will join Global Medical Affairs Rare Disease, a global organisation dedicated to improving outcomes for people living with rare diseases. The team works across therapy areas and functional disciplines to generate insights, shape medical strategy, drive scientific dialogue, support clinical care pathways, and build organisational readiness for current and future assets. 

The Evidence Generation function plays a central role in ensuring that our strategies are supported by high-quality evidence and that evidence activities are focused on the questions that matter most for patients, healthcare professionals, payers, regulators and healthcare systems. You will work with highly skilled colleagues across the global Rare Disease organisation and with regional and affiliate teams in key markets. 

Your skills and qualifications 

We are looking for a strategic, collaborative and scientifically strong leader who can operate with confidence in a global, matrixed organisation. You combine evidence generation expertise with a clear understanding of Medical Affairs impact, external stakeholder needs, cross-functional team needs and the realities of launch and lifecycle management. 

To be successful in this role, you will ideally have: 

• Over 10 years of evidence generation experience within the pharmaceutical or pharmaceutical service industry, including global, regional, or multi-country exposure, ideally in rare disease or specialty care.  

• Proven track record in influential leadership and ability to build and drive high-performing evidence activities and complex strategic projects 

• Strong understanding of pharmaceutical governance, compliance, quality and ethical requirements related to evidence generation and external collaborations. 

• Proven ability to build teams and lead cross-functional teams without direct authority, influence senior stakeholders and translate complex evidence topics into clear strategic recommendations. 

• Excellent communication skills in English, with the ability to create alignment, present to senior audiences and engage credibly with scientific experts. 

• A structured, impact-oriented approach to prioritisation, resource allocation and execution in a complex global environment. 

Working at Novo Nordisk 

At Novo Nordisk, we do not wait for change. We drive it. We are a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace experimentation, strive for excellence without fixating on perfection, and never shy away from opportunities to develop. From research and development to manufacturing, marketing, medical affairs and sales, we are all working to move the needle on patient care. 

Deadline